CN Stock MarketDetailed Quotes

300347 Hangzhou Tigermed Consulting

Watchlist
  • 51.71
  • +0.03+0.06%
Market Closed Jul 25 15:00 CST
44.73BMarket Cap26.44P/E (TTM)

Hangzhou Tigermed Consulting Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Hangzhou Tigermed Consulting Earnings Date

Currency: CNY

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

1.66B

-8.00%
EPS(YoY)

0.27

-59.09%
Analyst Rating

Strong Buy

Jul 25, 2024

Hangzhou Tigermed Consulting Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 2.200B--
--2024/Q2-- / 2.061B--
--2024/Q11.660B / 2.216B--
--2023/Q41.734B / 1.874B--
--2023/Q31.940B / 2.027B--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 2.200B--
--2024/Q2-- / 2.061B--
--2024/Q11.660B / 2.216B--
--2023/Q41.734B / 1.874B--
--2023/Q31.940B / 2.027B--

Unlock Free Earnings Estimates

Hangzhou Tigermed Consulting Earnings Reports

  • Hangzhou Tigermed Consulting: 2024 First Quarter Report

    Apr 25 12:00 ET

  • Tiger Pharmaceuticals: 2023 Annual Report

    Mar 28 12:00 ET

  • Tiger Pharmaceuticals: 2023 Annual Report Summary

    Mar 28 12:00 ET

  • Tiger Pharmaceuticals: Report for the third quarter of 2023

    Oct 27, 2023 12:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 25, 2024

    Strong Buy

    • Strong Buy

      84.21%

    • Buy

      15.79%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    % Chg